User profiles for Francois Bénard

François Bénard

Professor of Radiology, University of British Columbia
Verified email at bccrc.ca
Cited by 11092

Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results

…, S Rodrigue, R Lecomte, F Bénard - Journal of Nuclear …, 2004 - Soc Nuclear Med
Respiratory motion may reduce the sensitivity of 18 F-FDG PET for the detection of small
pulmonary nodules close to the base of the lungs. This motion also interferes with attempts to …

Prognostic value of FDG PET imaging in malignant pleural mesothelioma

F Bénard, D Sterman, RJ Smith… - The Journal of Nuclear …, 1999 - search.proquest.com
Despite several attempts at treating malignant pleural mesothelioma with various modalities,
mortality remains high, with median survival between 12 and 18 mo. This disease may …

[HTML][HTML] Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation

…, L Halabelian, CH Arrowsmith, F Bénard - Nature chemical …, 2022 - nature.com
Transmembrane protease, serine 2 (TMPRSS2) has been identified as key host cell factor
for viral entry and pathogenesis of SARS-CoV-2. Specifically, TMPRSS2 proteolytically …

[HTML][HTML] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography

F Bénard, D Sterman, RJ Smith, LR Kaiser, SM Albelda… - Chest, 1998 - Elsevier
Background:The diagnosis of malignant mesothelioma is a challenging medical problem.
CT often cannot differentiate between benign diffuse pleural thickening and malignant …

Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation

…, M Lépine, J Verreault, F Bénard - Journal of Nuclear …, 2003 - Soc Nuclear Med
Detection of relapse after completion of therapy in patients with Hodgkin’s disease (HD) and
non-Hodgkin’s lymphomas (NHL) constitutes an important challenge in modern medical …

Whole-body FDG-PET imaging in the management of patients with cancer

R Hustinx, F Bénard, A Alavi - Seminars in nuclear medicine, 2002 - Elsevier
Fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging is increasingly used
for the management of patients with cancer. The technique is now well accepted by most …

Imaging gliomas with positron emission tomography and single-photon emission computed tomography

F Bénard, J Romsa, R Hustinx - Seminars in nuclear medicine, 2003 - Elsevier
Over the last two decades the large volume of research involving various brain tracers has
shed invaluable light on the pathophysiology of cerebral neoplasms. Yet the question …

Quantitative gated PET for the assessment of left ventricular function in small animals

E Croteau, F Bénard, J Cadorette… - Journal of nuclear …, 2003 - Soc Nuclear Med
18 F-FDG PET can identify areas of myocardial viability and necrosis and provide useful
information on the effectiveness of experimental techniques designed to improve contractile …

Cyclotron production of 99mTc: experimental measurement of the 100Mo (p, x) 99Mo, 99mTc and 99gTc excitation functions from 8 to 18 MeV

K Gagnon, F Bénard, M Kovacs, TJ Ruth… - Nuclear medicine and …, 2011 - Elsevier
INTRODUCTION: The cyclotron-based 100 Mo(p,2n) 99m Tc transformation has been
proposed as a viable alternative to the reactor based 235 U(n,f) 99 Mo→ 99m Tc strategy for …

Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in …

R Hustinx, RJ Smith, F Benard, DI Rosenthal… - European journal of …, 1999 - Springer
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) studies imaging
FDG PET imaging is used to detect and stage head and neck cancers. However, the …